This inventor holds 2 USPTO granted patents and 9 published patent applications. Top assignee: Aileron Therapeutics, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yong Chang: Innovator in Cancer Treatment
Introduction
Yong Chang is a notable inventor based in Acton, MA (US), recognized for his contributions to cancer treatment through innovative methodologies. With a total of two patents to his name, he has made significant strides in the field of medical research.
Latest Patents
Chang's latest patents focus on the development of peptidomimetic macrocycles. These patents detail methods for treating solid tumors that lack a p53 deactivation mutation in a subject. Additionally, he has developed methods for treating liquid cancers under similar conditions. The peptidomimetic macrocycles he has created are designed for use in these treatments, showcasing his commitment to advancing cancer therapies.
Career Highlights
Yong Chang is currently associated with Aileron Therapeutics, Inc., where he continues to push the boundaries of cancer research. His work is pivotal in exploring new avenues for treatment, particularly for cancers that present unique challenges due to genetic mutations.
Collaborations
Chang collaborates with esteemed colleagues such as Hubert Chen and David Allen Annis, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yong Chang's work in developing novel treatments for cancer exemplifies the impact of innovative thinking in medicine. His patents and ongoing research hold promise for improving patient outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile